Comparative Effectiveness of Neoadjuvant Therapy and Upfront Resection for Patients with Resectable Pancreatic Adenocarcinoma: An Instrumental Variable Analysis.
Wilson Luiz da Costa-JúniorHop S Tran CaoKyle H SheetzXiangjun GuEdward C NortonNader N MassarwehPublished in: Annals of surgical oncology (2020)
In patients with resectable PDAC, NAT is associated with improved survival relative to upfront resection. Given the benefits of multimodality therapy and the challenges in receiving adjuvant therapy, consideration should be given to treating all PDAC patients with NAT.